Eledon Pharmaceuticals (ELDN) Operating Expenses (2016 - 2017)
Historic Operating Expenses for Eledon Pharmaceuticals (ELDN) over the last 4 years, with Q1 2017 value amounting to $3.9 million.
- Eledon Pharmaceuticals' Operating Expenses fell 6609.76% to $3.9 million in Q1 2017 from the same period last year, while for Sep 2017 it was $7.7 million, marking a year-over-year decrease of 8315.84%. This contributed to the annual value of $70.6 million for FY2024, which is 6413.26% up from last year.
- Latest data reveals that Eledon Pharmaceuticals reported Operating Expenses of $3.9 million as of Q1 2017, which was down 6609.76% from $3.8 million recorded in Q4 2016.
- In the past 5 years, Eledon Pharmaceuticals' Operating Expenses ranged from a high of $13.6 million in Q2 2016 and a low of $3.8 million during Q4 2016
- Over the past 4 years, Eledon Pharmaceuticals' median Operating Expenses value was $9.0 million (recorded in 2015), while the average stood at $8.5 million.
- Its Operating Expenses has fluctuated over the past 5 years, first surged by 17187.24% in 2015, then crashed by 6609.76% in 2017.
- Quarter analysis of 4 years shows Eledon Pharmaceuticals' Operating Expenses stood at $6.3 million in 2014, then soared by 76.84% to $11.1 million in 2015, then plummeted by 66.04% to $3.8 million in 2016, then increased by 3.51% to $3.9 million in 2017.
- Its last three reported values are $3.9 million in Q1 2017, $3.8 million for Q4 2016, and $9.3 million during Q3 2016.